Rapid detection of human mastadenovirus species B by recombinase polymerase amplification assay
Tao Wu, Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Chaoyou Hu, Haizhen Wu(East China University of Science and Technology), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Xiaojuan Zhu(Liaoning Normal University), Minghao Zhou(Jiangsu Provincial Center for Disease Control and Prevention), Xingchen Zhang, Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention)
Cited by 12
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204